AVE 25.0% 0.3¢ avecho biotechnology limited

targeting statins, page-26

  1. 34,916 Posts.
    lightbulb Created with Sketch. 480
    Yes ferret, the end result at OXR was a debacle. No guarantees no matter how big a company. Even the BHPs and TLSs have had their good and bad times, and of course we can see what happend to Centro from over $10 to a low of a couple of cents. That's why I think I prefer the speculative end of town. In for a good time, not a long time, opportunity to multiple money quickly. Once sold out, always keep a few just in case.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.